Annexon, Inc. (ANNX) vs ArriVent BioPharma, Inc. (AVBP)
A side-by-side comparison of Annexon, Inc. and ArriVent BioPharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANNX
Annexon, Inc.
$4.07HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
AVBP
ArriVent BioPharma, Inc.
$14.51HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — ANNX vs AVBP
growth of $100 · dividends reinvested · last 3yANNX -6.7% (-2.3%/yr)AVBP +42.3% (+12.5%/yr)AVBP compounded faster over this window
ANNX AVBP
ANNX vs AVBP: by the numbers
- •AVBP is the larger company ($676M vs $666M market cap).
Metrics side by side
Valuation
| Metric | ANNX | AVBP |
|---|---|---|
| P/B ratio | 3.58 | 1.84 |
Profitability
| Metric | ANNX | AVBP |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -108.93% | -44.63% |
| ROIC | -101.43% | -47.96% |
Growth (annualized)
| Metric | ANNX | AVBP |
|---|---|---|
| Total return CAGR (5Y) | -26.29% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.